MDT

95.91

-0.24%↓

136.91

+0.53%↑

VEEV

220.02

-1.38%↓

HQY

91.68

+0.19%↑

PHR.US

16.39

-3.02%↓

MDT

95.91

-0.24%↓

136.91

+0.53%↑

VEEV

220.02

-1.38%↓

HQY

91.68

+0.19%↑

PHR.US

16.39

-3.02%↓

MDT

95.91

-0.24%↓

136.91

+0.53%↑

VEEV

220.02

-1.38%↓

HQY

91.68

+0.19%↑

PHR.US

16.39

-3.02%↓

MDT

95.91

-0.24%↓

136.91

+0.53%↑

VEEV

220.02

-1.38%↓

HQY

91.68

+0.19%↑

PHR.US

16.39

-3.02%↓

MDT

95.91

-0.24%↓

136.91

+0.53%↑

VEEV

220.02

-1.38%↓

HQY

91.68

+0.19%↑

PHR.US

16.39

-3.02%↓

Home・Stock List・PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corp

Open

SectorHealthcare

30.87 -1.72

Buy Sell

Overview

Share price change

24h

Current

Min

30.65

Max

31.46

Key metrics
By Trading Economics
Income	-1.8M -21M
Sales	4.1M 83M
Profit margin	-25.695
Employees	756
EBITDA	4.8M -19M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+64.49% upside

Market Stats
By TradingEconomics
Market Cap	-123M 1.8B
Previous open	32.59
Previous close	30.87

News Sentiment

By Acuity

50%

141 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

52.655 / 56.31 Support & Resistance

PROCEPT BioRobotics Corp Chart

Past performance is not a reliable indicator of future results.

Related News

31 Dec 2025, 22:20 UTC

Major Market Movers

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 Dec 2025, 17:31 UTC

Major Market Movers

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 Dec 2025, 16:30 UTC

Major Market Movers

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 Dec 2025, 15:19 UTC

Major Market Movers

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 Dec 2025, 15:17 UTC

Major Market Movers

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 Dec 2025, 14:37 UTC

Major Market Movers

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

1 Jan 2026, 23:35 UTC

Market Talk

Gold Rises Amid Geopolitical Risks -- Market Talk

1 Jan 2026, 21:29 UTC

Acquisitions, Mergers, Takeovers

BlueScope: Transaction Completed on Terms Agreed When Deal Announced on Nov 13

1 Jan 2026, 21:29 UTC

Acquisitions, Mergers, Takeovers

BlueScope Sold Stake in JV to Tata Steel

1 Jan 2026, 21:28 UTC

Acquisitions, Mergers, Takeovers

BlueScope Steel Says Sale of Stake in Tata BlueScope Steel Completed on Dec 31

1 Jan 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

1 Jan 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 Dec 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 Dec 2025, 21:13 UTC

Acquisitions, Mergers, Takeovers

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 Dec 2025, 20:40 UTC

Market Talk

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 Dec 2025, 20:22 UTC

Market Talk

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 Dec 2025, 19:50 UTC

Market Talk

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 Dec 2025, 19:31 UTC

Market Talk

Precious Metals Cap Off Record Runs -- Market Talk

31 Dec 2025, 18:50 UTC

Market Talk

Global Equities Roundup: Market Talk

31 Dec 2025, 18:50 UTC

Market Talk

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 Dec 2025, 17:17 UTC

Market Talk

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 Dec 2025, 17:16 UTC

Major Market Movers

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 Dec 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

31 Dec 2025, 17:00 UTC

Acquisitions, Mergers, Takeovers

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 Dec 2025, 15:57 UTC

Acquisitions, Mergers, Takeovers

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 Dec 2025, 15:54 UTC

Market Talk

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 Dec 2025, 15:02 UTC

Major Market Movers

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 Dec 2025, 14:40 UTC

Acquisitions, Mergers, Takeovers

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 Dec 2025, 14:20 UTC

Market Talk

Crude Futures On Track to End the Year With Losses -- Market Talk

31 Dec 2025, 13:46 UTC

Market Talk

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

Peer Comparison

Price change

PROCEPT BioRobotics Corp Forecast

Price Target

By TipRanks

64.49% upside

12 Months Forecast

Average 51.75 USD 64.49%

High 65 USD

Low 38 USD

Based on 10 Wall Street analysts offering 12 month price targets forPROCEPT BioRobotics Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

Buy

Hold

Sell

Based on 10 analysts giving stock ratings to PROCEPT BioRobotics Corp - Dist in the past 3 months.

Technical Score

By Trading Central

52.655 / 56.31Support & Resistance

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

141 / 374 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.